PubRank

Tetsuro Kondo

Author PubWeight™ 25.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002 1.90
2 Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science 2010 1.65
3 Effectiveness of erlotinib in advanced non-small cell lung cancer in cases of gefitinib resistance after treatment of more than 6 months. Onkologie 2012 1.51
4 Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2003 1.39
5 Middle mediastinal thymoma. J Thorac Cardiovasc Surg 2002 1.32
6 Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2007 1.10
7 Management of subsolid nodules. Chest 2013 1.09
8 Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung. Eur J Cardiothorac Surg 2004 1.02
9 Correlations between thin-section CT findings, histopathological and clinical findings of small pulmonary adenocarcinomas. Lung Cancer 2010 1.01
10 Growth rate of lung cancer recognized as small solid nodule on initial CT findings. Eur J Radiol 2011 0.99
11 Cbln1 regulates rapid formation and maintenance of excitatory synapses in mature cerebellar Purkinje cells in vitro and in vivo. J Neurosci 2008 0.93
12 Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009 0.92
13 Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findings. Eur J Radiol 2010 0.90
14 Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer. Ann Thorac Surg 2005 0.89
15 Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials. J Thorac Oncol 2011 0.85
16 Correlations of thin-section computed tomographic, histopathological, and clinical findings of adenocarcinoma with a bubblelike appearance. J Comput Assist Tomogr 2010 0.83
17 Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung. Anticancer Res 2012 0.81
18 Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer. BMC Cancer 2014 0.80
19 Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation. Cancer Chemother Pharmacol 2013 0.79
20 Phosphorylation of delta2 glutamate receptors at serine 945 is not required for cerebellar long-term depression. Keio J Med 2008 0.78
21 Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma. Eur J Radiol 2011 0.78
22 ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma. Eur J Radiol 2013 0.78
23 Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer. Cancer Chemother Pharmacol 2012 0.77
24 Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy. Cancer Chemother Pharmacol 2006 0.77
25 Cbln1 binds to specific postsynaptic sites at parallel fiber-Purkinje cell synapses in the cerebellum. Eur J Neurosci 2009 0.77
26 Phase II study of paclitaxel and irinotecan with intercalated gefitinib in patients with advanced non-small-cell lung cancer. Am J Clin Oncol 2010 0.76
27 Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical course. Lung Cancer 2010 0.76
28 Nedaplatin and irinotecan for patients with recurrent small cell lung cancer. J Exp Ther Oncol 2012 0.75
29 Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapy. Intern Med 2013 0.75
30 Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2003 0.75
31 A phase II study of docetaxel and infusional cisplatin in advanced non-small-cell lung cancer. Chemotherapy 2005 0.75
32 Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer. Cancer Chemother Pharmacol 2006 0.75
33 Prospective study of second-line chemotherapy for non-small cell lung cancer selected according to EGFR gene status. J Exp Ther Oncol 2010 0.75